Endonovo Therapeutics, Inc. announced initial sales of SofPulse® units into a VA hospital in Texas. SofPulse® is Endonovo’s FDA-Cleared non-invasive device for reduction of postoperative pain and edema. SofPulse® represents a low-cost, drug-free solution to reduce use of opioids following surgical procedures and help prevent addiction. The therapy is non-invasive and non-pharmacologic, with no known side effects and no potential for overdose or dependency. The Veterans Affairs Texas hospital is one of the department's large hospitals, serving 27 Counties in Texas, and offers treatment for complex surgical conditions while at the same time promoting a multimodal approach for the treatment of postoperative pain aimed at reducing narcotics, which now includes SofPulse®.